Comparative Effectiveness and Safety of Denosumab Versus Bisphosphonates in Osteoporosis Management Among Patients with Inflammatory Bowel Disease: A US Propensity Matched Cohort Study

被引：0
|
作者：
Khataniar, H. [1 ]
Desai, A. [2 ]
Kochhar, G. [2 ]
机构：
[1] Allegheny Hlth Network, Dept Med, Pittsburgh, PA USA
[2] Allegheny Hlth Network, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.0873
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0699
引用
收藏
页码：i1366 / i1367
页数：2
相关论文
共 50 条
  • [31] Comparative safety of baricitinib versus TNFi in rheumatoid arthritis management in the French population: A propensity score-matched cohort study
    Thurin, Nicolas H.
    Grelaud, Angela
    Bernard, Marie-Agnes
    Grolleau, Adeline
    Bignon, Emmanuelle
    Germain, Vincent
    Richez, Christophe
    Polinski, Jennifer
    Lassalle, Regis
    Blin, Patrick
    Droz-Perroteau, Cecile
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 570 - 570
  • [32] Comparative effectiveness and cardiovascular safety of romosozumab versus teriparatide in patients with osteoporosis: a population-based cohort study
    Masuda, Soichiro
    Fukasawa, Toshiki
    Matsuda, Shuichi
    Yoshida, Satomi
    Kawakami, Koji
    OSTEOPOROSIS INTERNATIONAL, 2024, 35 (12) : 2165 - 2174
  • [33] Comparative effectiveness and safety of low versus high dose rivaroxaban and apixaban for atrial fibrillation: A propensity score-matched cohort study
    Perreault, Sylvie
    Dragomir, Alice
    Cote, Robert
    White-Guay, Brian
    Lenglet, Aurelie
    Dorais, Marc
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 176 - 177
  • [34] Effectiveness and safety of prophylactic anticoagulation among hospitalized patients with inflammatory bowel disease
    Dawwas, Ghadeer K.
    Cuker, Adam
    Schaubel, Douglas E.
    Lewis, James D.
    BLOOD ADVANCES, 2024, 8 (05) : 1272 - 1280
  • [35] Comparative Effectiveness of Denosumab versus Bisphosphonates among Treatment-Experienced Postmenopausal Women with Osteoporosis in the U. S. Medicare Program
    Curtis, Jeffrey R.
    Arora, Tarun
    Liu, Ye
    Lin, Tzu-Chieh
    Spangler, Leslie
    Brunetti, Vanessa C.
    Stad, Robert
    McDermott, Michele
    Bradbury, Brian
    Kim, Min
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 534 - 534
  • [36] Non-Alcoholic Fatty Liver Disease Adds to the Cardiovascular Risk of Inflammatory Bowel Disease: A Fact or Myth? A US Cohort Propensity Matched Study
    Soni, Aakriti
    Desai, Aakash
    Kochhar, Gursimran S.
    Abraham, George M.
    Waghray, Nisheet
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S699 - S700
  • [37] RISK OF MAJOR ADVERSE CARDIOVASCULAR OUTCOMES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A NATIONWIDE MATCHED COHORT STUDY
    Krishnan, Arunkumar
    Zitun, Mohamed
    Hadi, Yousaf
    Mukherjee, Diptasree
    Cohen, Ethan M.
    Diab, Kareem
    Shabih, Sarah
    Hageboeck, Katherine
    Singh, Shailendra
    Thakkar, Shyam
    Hadam, Jennifer
    GASTROENTEROLOGY, 2023, 164 (06) : S452 - S453
  • [38] Editorial: effectiveness and safety of vedolizumab in a matched cohort of elderly and non-elderly patients with inflammatory bowel disease - the IG-IBD LIVE study
    Lee, Helen
    Khan, Nabeel
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (04) : 731 - 732
  • [39] Cutaneous Morbidity Among Inflammatory Bowel Disease Patients: A Cohort Study
    Vide, Julia
    Osorio, Filipa
    Costa-Silva, Miguel
    Lopes, Sofia
    Azevedo, Filomena
    Dias, Claudia Camila
    Magina, Sofia
    Magro, Fernando
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (04): : 442 - 451
  • [40] Comparative Effectiveness and Safety of Infliximab and Adalimumab in Inflammatory Bowel Diseases: A Nationwide Danish Cohort Study
    不详
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S260 - S260
12345